Literature DB >> 31531194

Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1).

Jianwen A Feng1, Patrick Lee1, Moulay Hicham Alaoui1, Kathy Barrett1, Georgette Castanedo1, Robert Godemann2, Paul McEwan3, Xiaolu Wang2, Ping Wu1, Yamin Zhang4, Seth F Harris1, Steven T Staben1.   

Abstract

We previously disclosed a series of type I 1/2 inhibitors of NF-κB inducing kinase (NIK). Inhibition of NIK by these compounds was found to be strongly dependent on the inclusion and absolute stereochemistry of a propargyl tertiary alcohol as it forms critical hydrogen bonds (H-bonds) with NIK. We report that inhibition of protein kinase D1 (PKD1) by this class of compounds is not dependent on H-bond interactions of this tertiary alcohol. This feature was leveraged in the design of highly selective inhibitors of PKD1 that no longer inhibit NIK. A structure-based hypothesis based on the position and flexibility of the α-C-helix of PKD1 vs NIK is presented.

Entities:  

Year:  2019        PMID: 31531194      PMCID: PMC6746091          DOI: 10.1021/acsmedchemlett.8b00658

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  1 in total

Review 1.  Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases.

Authors:  Jing Cheng; Xuexin Feng; Zhiqiang Li; Feilong Zhou; Jin-Ming Yang; Yujun Zhao
Journal:  RSC Med Chem       Date:  2021-01-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.